1. Home
  2. NUVL vs MOD Comparison

NUVL vs MOD Comparison

Compare NUVL & MOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nuvalent Inc.

NUVL

Nuvalent Inc.

HOLD

Current Price

$104.39

Market Cap

7.1B

Sector

Health Care

ML Signal

HOLD

Logo Modine Manufacturing Company

MOD

Modine Manufacturing Company

HOLD

Current Price

$142.01

Market Cap

8.2B

ML Signal

HOLD

Company Overview

Basic Information
Metric
NUVL
MOD
Founded
2017
1916
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Auto Parts:O.E.M.
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
7.1B
8.2B
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
NUVL
MOD
Price
$104.39
$142.01
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
14
5
Target Price
$134.29
$177.60
AVG Volume (30 Days)
828.0K
1.2M
Earning Date
10-30-2025
02-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
14.04
EPS
N/A
3.47
Revenue
N/A
$2,685,700,000.00
Revenue This Year
N/A
$19.06
Revenue Next Year
N/A
$15.41
P/E Ratio
N/A
$40.31
Revenue Growth
N/A
8.10
52 Week Low
$55.54
$64.79
52 Week High
$112.88
$166.94

Technical Indicators

Market Signals
Indicator
NUVL
MOD
Relative Strength Index (RSI) 51.87 43.99
Support Level $103.52 $148.03
Resistance Level $107.99 $165.83
Average True Range (ATR) 3.18 10.49
MACD -0.93 -1.21
Stochastic Oscillator 10.43 19.83

Price Performance

Historical Comparison
NUVL
MOD

About NUVL Nuvalent Inc.

Nuvalent Inc is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer. All of the Company's operations are in the United States. The company is engaged in developing small molecules that are designed to overcome the limitations of existing therapies for clinically validated kinase targets. The product candidates of the company include NVL-520, which is being developed for patients with ROS1-positive non-small cell lung cancer (NSCLC), NVL-655, which is being developed for patients with anaplastic lymphoma kinase (ALK)-positive NSCLC, NVL-330, is a brain-penetrant human epidermal growth factor receptor 2 (HER2)-selective inhibitor designed to address the combined medical need of treating tumors driven by HER2ex20.

About MOD Modine Manufacturing Company

Modine Manufacturing Co provides thermal management solutions to diversified markets and customers. The company provides engineered heat transfer systems and heat transfer components for use in on- and off-highway original equipment manufacturer (OEM) vehicular applications in the United States. It offers powertrain cooling products, such as engine cooling assemblies, radiators, condensers, and charge air coolers; auxiliary cooling products, including power steering and transmission oil coolers. Its operating segments include Climate Solutions and Performance Technologies.

Share on Social Networks: